Aran Labrijn, PhDPrincipal Scientist, Antibody Research and Technology at GenmabSpeaker
Profile
Dr. Aran F. Labrijn has been working in the field of recombinant antibodies for more than 20 years. He holds a PhD in molecular immunology from the University of Amsterdam (2004). In 2002, he joined Genmab where he is currently a principal scientist in the department of antibody research and technology with a focus on understanding antibody biology and Fc-engineering. These studies have led to the development of therapeutic antibody formats, including Genmab’s bispecific antibody technology platform (DuoBody®).